Aarti Pharmalabs Share Price

    NSE
    860.55
    -12.30 (1.39%)
    AARTIPHARM • 27 Jun, 2025 | 03:29 PM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Aarti Pharmalabs Stock Performance

    1W Return0.74
    1Y Return40.60
    Today's Low857
    Prev. Close872.85
    Mkt Cap (Cr.)7,790.50
    1M Return-2.38
    3Y Return0.00
    52-Week High949.5
    Open880.95
    PE Ratio30.27
    6M Return26.88
    Today's High881
    52-Week Low551.05
    Face Value5

    Aarti Pharmalabs Company background

    Founded in: 2019
    Managing director: Narendra Jagannath Salvi
    Aarti Pharmachem Limited, formerly known as Aarti Organics Limited, was incorporated as a Public Limited Company in 2019. The Company changed the name from Aarti Organics Limited to Aarti Pharmachem Limited on July 1, 2021. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anticancer, AntiAsthma, AntiHypertensive etc.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.The RD centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company has commenced operations for its semicommercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity was enhanced to 5000 TPA in 202324.

    As of 27 Jun, 2025, Aarti Pharmalabs share price is ₹859.6. The stock opened at ₹881 and had closed at ₹872.8 the previous day. During today’s trading session, Aarti Pharmalabs share price moved between ₹857.00 and ₹881.00, with an average price for the day of ₹869.00. Over the last 52 weeks, the stock has recorded a low of ₹551.05 and a high of ₹949.50. In terms of performance, Aarti Pharmalabs share price has increased by 26.9% over the past six months and has increased by 41.74% over the last year.

    Read More
    View details of Market Depth

    Aarti Pharmalabs Fundamental

    Market Cap (in crs)

    7,790.50

    Face Value

    5

    Turnover (in lacs)

    1,436.49

    Key Metrics

    Qtr Change %
    55.98% Gain from 52W Low
    14.7
    Dividend yield 1yr %
    Below industry Median
    0.4

    Aarti Pharmalabs Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Aarti Pharmalabs Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    563.78 Cr
    537.78 Cr
    458.03 Cr
    555.49 Cr
    505.77 Cr
    Aarti Pharmalabs Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022
    2125.19 Cr
    1857.5 Cr
    1947.55 Cr
    1202.46 Cr
    Aarti Pharmalabs Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    88.34 Cr
    73.99 Cr
    54.62 Cr
    55.45 Cr
    65.25 Cr
    Aarti Pharmalabs Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022
    272.4 Cr
    216.9 Cr
    193.49 Cr
    122.25 Cr

    Aarti Pharmalabs Result Highlights

    • Aarti Pharmalabs Ltd reported a 6.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 4.5%.

    • Its expenses for the quarter were down by 6.8% QoQ and 3.5% YoY.

    • The net profit decreased 11.8% QoQ and increased 52.2% YoY.

    • The earnings per share (EPS) of Aarti Pharmalabs Ltd stood at 7.2 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Aarti Pharmalabs

    Promoter
    44.3%
    Foreign Institutions
    7.4%
    Mutual Funds
    0.8%
    Domestic Institutions
    7.5%
    Public
    40.8%
    Promoter
    44.7%
    Foreign Institutions
    8.6%
    Mutual Funds
    3.9%
    Domestic Institutions
    10.4%
    Public
    36.3%
    Promoter
    46.1%
    Foreign Institutions
    7.4%
    Mutual Funds
    4.9%
    Domestic Institutions
    11.3%
    Public
    35.2%
    Promoter
    46.5%
    Foreign Institutions
    7.1%
    Mutual Funds
    4.7%
    Domestic Institutions
    11.5%
    Public
    35%
    Promoter
    46.5%
    Foreign Institutions
    8.3%
    Mutual Funds
    2.7%
    Domestic Institutions
    10%
    Public
    35.2%
    Promoter
    46.5%
    Foreign Institutions
    8.2%
    Mutual Funds
    2%
    Domestic Institutions
    9.9%
    Public
    35.4%

    Aarti Pharmalabs Technical Analysis

    Moving Averages Analysis
    860.55
    Current Price
    Bullish Moving Averages
    7
    Bearish Moving Averages
    9
    5Day EMA
    864.40
    10Day EMA
    869.00
    12Day EMA
    870.50
    20Day EMA
    870.60
    26Day EMA
    865.80
    50Day EMA
    837.30
    100Day EMA
    787.90
    200Day EMA
    723.80
    5Day SMA
    865.10
    10Day SMA
    863.60
    20Day SMA
    887.60
    30Day SMA
    883.80
    50Day SMA
    828.50
    100Day SMA
    776.70
    150Day SMA
    729.10
    200Day SMA
    705.60
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    99214 Rs
    178244 Rs
    Week Rs
    135761 Rs
    284647 Rs
    Month Rs
    142140 Rs
    308592 Rs
    865.85
    Pivot
    Resistance
    First Resistance
    874.70
    Second Resistance
    889.85
    Third Resistance
    898.70
    Support
    First Support
    850.70
    Second support
    841.85
    Third Support
    826.70
    Relative Strength Index
    48.73
    Money Flow Index
    45.84
    MACD
    4.76
    MACD Signal
    12.56
    Average True Range
    31.91
    Average Directional Index
    26.72
    Rate of Change (21)
    -4.91
    Rate of Change (125)
    35.93
    Name
    Holding Percent
    Ntasain Discovery Master Fund
    2.21
    Life Insurance Corporation Of India
    6.06

    Aarti Pharmalabs Latest News

    25 JUN 2025 | Wednesday

    Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window

    18 JUN 2025 | Wednesday

    Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 MAY 2025 | Tuesday

    Aarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    View More

    Aarti Pharmalabs Share Price FAQs

    Aarti Pharmalabs share price is ₹860.55 in NSE and ₹859.25 in BSE as on 27/6/2025.

    Aarti Pharmalabs share price in the past 1-year return was 40.59. The Aarti Pharmalabs share hit a 1-year low of Rs. 551.05 and a 1-year high of Rs. 949.5.

    The market cap of Aarti Pharmalabs is Rs. 7790.5 Cr. as of 27/6/2025.

    The PE ratios of Aarti Pharmalabs is 30.27 as of 27/6/2025.

    The PB ratios of Aarti Pharmalabs is 4.22 as of 27/6/2025

    The Mutual Fund Shareholding in Aarti Pharmalabs was 0.78% at the end of 27/6/2025.

    You can easily buy Aarti Pharmalabs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Aarti Pharmalabs share price is ₹949.5 and ₹551.05 as of 27/6/2025.

    Please be aware that Aarti Pharmalabs stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    805.40
    +8.35 (+1.05%)
    1,515.40
    +20.10 (+1.34%)
    2,014.90
    -6.90 (-0.34%)
    1,608.00
    -8.00 (-0.50%)
    3,441.10
    -0.70 (-0.02%)
    Top Gainers
    323.45
    +10.95 (+3.50%)
    2,358.70
    +68.90 (+3.01%)
    7,308.50
    +207.00 (+2.91%)
    857.70
    +21.60 (+2.58%)
    2,646.30
    +60.10 (+2.32%)
    Top Losers
    1,124.30
    -21.10 (-1.84%)
    1,301.00
    -20.50 (-1.55%)
    6,019.50
    -87.50 (-1.43%)
    265.05
    -3.47 (-1.29%)
    261.86
    -3.32 (-1.25%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -